Darby S, McGale P, Correa C, Taylor C, Arriagada R, Early Breast Cancer Trialists’ Collaborative Group, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

Article  CAS  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med. 1995;333:1444–55.

Article  Google Scholar 

Kunkler IH, Williams LJ, Lack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388:585–94.

Article  PubMed  Google Scholar 

Whelan TJ, Smith S, Parpia S, Fyles AQ, Bane A, Liu FF, et al. Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer. N Engl J Med. 2023;389:612–9.

Article  PubMed  Google Scholar 

Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023;14:112–32.

Article  PubMed  Google Scholar 

Meattini I, Becherini C, Boersma L, Kaidar-Person O, Nader Marta G, Montero A, et al. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022;23:e21-31.

Article  PubMed  Google Scholar 

NCCN Guidelines. 2024; Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed Feb 2024

Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, START Trialists’ Group, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.

Article  CAS  PubMed  Google Scholar 

Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, START Trialists’ Group, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331–41.

Article  CAS  PubMed  Google Scholar 

Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.

Article  CAS  PubMed  Google Scholar 

Burstein HJ, Curigliano G, Thurlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216–35.

Article  CAS  PubMed  Google Scholar 

Brunt MA, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613–26.

Article  Google Scholar 

Mitsuyoshi T, Ono Y, Ashida R, Yamashita M, Tanabe H, Takebe S, et al. Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study). Jpn J Clin Oncol. 2023;53:174–8.

Article  PubMed  Google Scholar 

Giugliano FM, Falivene S, Esposit E, Di Franco R, D’Aiuto M, Lanza F, et al. Short-course radiotherapy in elderly women with breast cancer: Comparison by age, comorbidity index and toxicity. Int J Surg. 2016;33(Suppl 1):S92–6.

Article  PubMed  Google Scholar 

Banerjee R, George M, Gupta A. Maximizing home time for persons with cancer. JCO Oncol Pract. 2021;17:513–6.

Article  PubMed  Google Scholar 

Arsenault J, Parpia S, Goldberg M, Rakovitch E, Reiter H, Doherty M, et al. Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2020;107:943–8.

Article  PubMed  Google Scholar 

Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A, et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol. 2016;120:114–8.

Article  PubMed  PubMed Central  Google Scholar 

Goldsmith C, Haviland J, Tsang Y, Sydenham M, Yarnolg J, FAST Trialists’ Group. Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? Radiother Oncol. 2011;100:236–40.

Article  PubMed  Google Scholar 

Nozaki M, Kagami Y, Shibata T, Nakamura K, Ito Y, Nishimura Y, et al. A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 2019;49:57–62.

Article  PubMed  Google Scholar 

Liu T, Li S, Ding S, Qiu J, Ren C, Chen J, et al. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis. EClinicalMedicine. 2023;64: 102246.

Article  PubMed  PubMed Central  Google Scholar 

Gathani T, Reeves G, Brioggio J, Barnes I. Ethnicity and the tumour characteristics of invasive breast cancer in over 116,500 women in England. Br J Cancer. 2021;125:611–7.

Article  PubMed  PubMed Central  Google Scholar 

Nozaki M, Kagami Y, Machida R, Nakamura K, Ito Y, et al. Final analysis of a multicenter single-arm confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 2021;51:865–71.

Article  PubMed  Google Scholar